Growth opportunities Target life science and healthcare customers in Switzerland and Europe that require precision instrumentation, diagnostics components, and high-reliability automation, leveraging IMI Life Science's expertise in electron multipliers, detectors, valves, and precision pumps to address early-disease detection and patient-centered care.

Technology integration Position IMI Life Science as a supplier of integrated critical components and subsystems compatible with IBM Cognos Analytics, Microsoft Azure Data Factory, Salesforce, and cloud-enabled workflows, offering data-enabled monitoring, traceability, and predictive maintenance for life-science manufacturing and diagnostics customers.

Industrial automation Capitalize on recent partnerships and expansions in the automation space by targeting OEMs and system integrators (like DAS) seeking advanced design and factory automation capabilities to accelerate instrument production and reduce time-to-market.

Strategic endorsements Leverage leadership changes and board-level collaboration signals to approach potential buyers and partners who value stable, customer-focused governance, positioning IMI as a reliable supplier capable of long-term commitments in critical care instrumentation.

Revenue alignment Explore cross-sell opportunities by engaging customers in adjacent markets within the broader life sciences and analytical instrumentation ecosystem, given the overlapping use of high-precision components and HV power supplies across diagnostics, medical devices, and research labs.